Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Revenue of Precipio, Inc. (PRPO)
Revenue in 2023 (TTM): $15.2 M
According to Precipio, Inc.'s latest financial reports the company's current revenue (TTM) is $15.2 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Precipio, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $15.2 M | $6.02 M | $-4,318,000 | $-5,853,000 | $-5,853,000 |
| 2022 | $9.41 M | $2.51 M | $-10,646,000 | $-12,178,000 | $-12,203,000 |
| 2021 | $8.85 M | $2.39 M | $-7,053,000 | $-8,517,000 | $-8,550,000 |
| 2020 | $6.09 M | $1.15 M | $-8,772,000 | $-10,598,000 | $-12,230,000 |
| 2019 | $3.13 M | $219 K | $-8,223,000 | $-13,313,000 | $-13,243,000 |
| 2018 | $2.86 M | $225 K | $-7,962,000 | $-15,973,000 | $-15,694,000 |
| 2017 | $1.72 M | $292 K | $-5,453,000 | $-20,694,000 | $-20,694,000 |
| 2016 | $1.56 M | $-205,000 | $-1,600,000 | $-8,269,000 | $-7,616,000 |
| 2015 | $1.65 M | $-287,000 | $-8,649,000 | $-10,138,000 | $-32,954,000 |
| 2014 | $27.08 M | $9.72 M | $-10,505,000 | $-13,418,000 | $-13,942,000 |
| 2013 | $27.54 M | $12.5 M | $-12,651,000 | $-16,041,000 | $-15,987,000 |
| 2012 | $31.48 M | $15.01 M | $-5,015,000 | $-8,181,000 | $-8,327,000 |
| 2011 | $31.97 M | $18.44 M | $-830,000 | $-9,737,000 | $-9,782,000 |
| 2010 | $20.05 M | $9.76 M | $-2,272,000 | $-2,984,000 | $-3,134,000 |
| 2009 | $22.02 M | $11.61 M | $-1,044,000 | $-1,878,000 | $-1,920,000 |
| 2008 | $23.99 M | $13.65 M | $600 K | $-282,000 | $-495,000 |
| 2007 | $23.18 M | $12.69 M | $-981,000 | $-1,931,000 | $-2,107,000 |
| 2006 | $23.42 M | $11.37 M | $-973,000 | $-2,933,000 | $-3,431,000 |
| 2005 | $25.83 M | $12.33 M | $1.77 M | $-4,958,000 | $-14,993,000 |
| 2004 | $33.79 M | $9.19 M | $-6,755,000 | $-34,466,000 | $-34,372,000 |
| 2003 | $33.87 M | $9.55 M | $-7,437,000 | $-22,893,000 | $-22,958,000 |
| 2002 | $37.55 M | $17.99 M | $-18,284,000 | $-21,260,000 | $-21,365,000 |
| 2001 | $38.47 M | $21.27 M | $-6,059,000 | $-7,377,000 | $-7,401,000 |
| 2000 | $25.88 M | $14.99 M | $-7,569,000 | $-8,481,000 | $-8,661,000 |
| 1999 | $23.03 M | $12.46 M | $-5,369,761 | $-8,081,613 | $-9,826,886 |